David M. Berman, Executive of Immunocore Holdings IMCR, has filed 0 purchases and 24 sales on the open market. Over the past 12 months that comes to a net sale of $7.4M. The latest trade was on 02/18.

DB

DB

David M. Berman

Head of R&d

Company

Immunocore Holdings IMCR

First filing

24/02/21

Trades

57 trades

Buys / sales

0 / 24

12-month net buying

−$7.4M

Last trade

02/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Immunocore HoldingsIMCR	Open-market sale	02/18	02/19	5,965 sh	$32.35	$192,967.75	−50.4%
Immunocore HoldingsIMCR	Open-market sale10b5-1 plan	25/12/04–25/12/05	25/12/08	31,913 sh2 trades	$40.26avg.	$1,284,748.74	−100.0%
Immunocore HoldingsIMCR	Open-market sale10b5-1 plan	25/11/26–25/11/28	25/12/01	74,925 sh2 trades	$40.12avg.	$3,005,825.37	−100.0%
Immunocore HoldingsIMCR	Open-market sale10b5-1 plan	25/11/24–25/11/25	25/11/26	18,120 sh2 trades	$40.03avg.	$725,340.6	−100.0%
Immunocore HoldingsIMCR	Open-market sale10b5-1 plan	25/09/30	25/10/02	61,849 sh	$35.23	$2,178,940.27	−100.0%
Immunocore HoldingsIMCR	Open-market sale10b5-1 plan	25/09/12–25/09/15	25/09/16	22,732 sh3 trades	$35.66avg.	$810,701.16	−100.0%
Immunocore HoldingsIMCR	Open-market sale10b5-1 plan	25/09/10–25/09/11	25/09/12	50,419 sh3 trades	$36.20avg.	$1,824,967.24	−100.0%
Immunocore HoldingsIMCR	Open-market sale10b5-1 plan	24/02/28	24/03/01	36,509 sh4 trades	$68.59avg.	$2,504,158.49	−100.0%
Immunocore HoldingsIMCR	Open-market sale10b5-1 plan	24/02/26–24/02/27	24/02/28	83,491 sh6 trades	$70.79avg.	$5,910,317.77	−100.0%